Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BURNING ROCK BIOTECH LIMITED

(BNR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Burning Rock Biotech : Narrows Q1 Loss, Revenue Rises; Medical Chief Resigns

05/25/2021 | 04:14am EDT


© MT Newswires 2021
All news about BURNING ROCK BIOTECH LIMITED
09/14BURNING ROCK BIOTECH : and CStone Pharmaceuticals reached a strategic collaborat..
PU
09/14BURNING ROCK BIOTECH : deepens cooperation with Illumina to promote development ..
PU
09/14BURNING ROCK BIOTECH : initiates the first prospective, multi-center pan-cancer ..
PU
09/14BURNING ROCK BIOTECH : Dx Launches Magnis BR to Innovate Total Process Automatio..
PU
09/14BURNING ROCK BIOTECH : announces the completion of the Series C financing of RMB..
PU
09/14BURNING ROCK BIOTECH : China's first NGS cancer testing kit made by Burning Rock..
PU
09/14BURNING ROCK BIOTECH : Dx Honored with 2018 Guangzhou Hi-tech “Unicorn&rdq..
PU
09/14BURNING ROCK BIOTECH : Dx Certified by the Certification of ISO 13485 Quality Ma..
PU
09/14BURNING ROCK BIOTECH : and Illumina Collaborate on Molecular Diagnostics for Onc..
PU
08/31SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Tuesday
MT
More news
Analyst Recommendations on BURNING ROCK BIOTECH LIMITED
More recommendations
Financials
Sales 2021 503 M 78,0 M 78,0 M
Net income 2021 -395 M -61,2 M -61,2 M
Net cash 2021 1 443 M 224 M 224 M
P/E ratio 2021 -33,3x
Yield 2021 -
Capitalization 13 233 M 2 049 M 2 051 M
EV / Sales 2021 23,4x
EV / Sales 2022 17,1x
Nbr of Employees 938
Free-Float 72,4%
Chart BURNING ROCK BIOTECH LIMITED
Duration : Period :
Burning Rock Biotech Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BURNING ROCK BIOTECH LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 126,57 CNY
Average target price 211,13 CNY
Spread / Average Target 66,8%
EPS Revisions
Managers and Directors
Yu Sheng Han Chairman & Chief Executive Officer
Leo Li Chief Financial Officer & Director
Zhi Hong Zhang Chief Technology Officer
Shao Kun Chuai Chief Operating Officer & Director
Wendy Hayes Independent Director
Sector and Competitors